Science Explorer Back to mapMap
Discussion
Researcher · Morristown Medical Center · United States

Charles Michael Farber

Charles Michael Farber publishes mostly in Genetics, Pathology and Forensic Medicine and Oncology, on topics such as Chronic Lymphocytic Leukemia Research, Lymphoma Diagnosis and Treatment and Spectroscopy Techniques in Biomedical and Chemical Research.

ORCID 0000-0002-2753-6986 OpenAlex
World rank
#1,090,540
of 7,710,434 ranked researchers
Rank in United States
#353,084
of 1,627,098
Works
108
Citations
3.4k
Citations per work
31.9
h-index
28
i10-index 53Top 14% in Genetics (Medicine)
Charles Michael Farber

What does Charles Michael Farber research?

Charles Michael Farber's work is mostly in Medicine (52%), Agricultural and Biological Sciences (6%), Immunology and Microbiology (6%).

Health Sciences: 56 works · 51.5% of their workMedicine: 56 works · 51.5% of their workGenetics: 23 works · 20.9% of their workPathology and Forensic Medicine: 17 works · 16.0% of their workOncology: 9 works · 8.7% of their workHematology: 6 works · 5.9% of their workEverything else: 40 works · 37.3% of their workLife Sciences: 12 works · 11.2% of their workAgricultural and Biological Sciences: 6 works · 5.6% of their workPlant Science: 6 works · 5.6% of their workImmunology and Microbiology: 6 works · 5.6% of their workImmunology: 6 works · 5.6% of their workTHEIR WORKCharles MichaelFarber108works
Life Sciences11%Health Sciences52%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Medicine5651.5%
  2. Everything else4037.3%
    1. Agricultural and Biological Sciences65.6%
    2. Immunology and Microbiology65.6%
  1. 1Genetics21% of their works
  2. 2Pathology and Forensic Medicine16% of their works
  3. 3Oncology9% of their works
  4. 4Hematology6% of their works
  5. 5Immunology6% of their works
  6. 6Plant Science6% of their works

Research topics

Which keywords describe Charles Michael Farber's research?

The keywords of their largest research topics: Rituximab, Chronic Lymphocytic Leukemia, Genomic Aberrations, Classification, Lymphoma, Infrared Spectroscopy, Raman Spectroscopy and Fc Receptors.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 17 words, with their numbers
  1. Rituximab992 topics
  2. Chronic Lymphocytic Leukemia541 topic
  3. Genomic Aberrations541 topic
  4. Classification451 topic
  5. Lymphoma451 topic
  6. Infrared Spectroscopy121 topic
  7. Raman Spectroscopy121 topic
  8. Fc Receptors111 topic
  9. Genetic Mutations111 topic
  10. Primary Immunodeficiency111 topic
  11. Therapeutic Antibodies111 topic
  12. Multivariate Calibration101 topic
  13. Near-Infrared Spectroscopy101 topic
  14. BCR-ABL81 topic
  15. Imatinib81 topic
  16. Diagnosis Criteria71 topic
  17. International Myeloma Working Group71 topic

Where does Charles Michael Farber work?

Charles Michael Farber's main affiliation in the publication record is Morristown Medical Center, United States.

How many publications and citations does Charles Michael Farber have?

OpenAlex counts 108 works and 3,446 citations for Charles Michael Farber, an h-index of 28, ranking #1,090,540 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Charles Michael Farber. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.